Etiology of Diarrhea in Guinea-Bissau and in Finland
1 other identifier
observational
920
2 countries
3
Brief Summary
Diarrhoea is the leading cause of death in the world with 2.2 million deaths every year. The majority of deaths are among children in developing countries, but the travellers encounter the disease as well. The studies on the aetiology have suffered from serious methodological deficiencies and the results are even controversial. At the same time, the current diagnostic methods are inadequate. The investigators have recently developed novel multiplex RT-PCR methods to cover the majority of diarrhoeal pathogens. The present study is a collaboration between Finland and Sweden/Guinea-Bissau. The aim is to characterize the causative agents of diarrhoea (a) in Finnish volunteers before and after a travel to tropical areas and, (b) in inhabitants of endemic areas in Guinea-Bissau. For these purposes stool samples will be collected from volunteers of different age groups and from healthy volunteers as well as those with diarrhea both in Guinea-Bissau and in Finland. In addition to pathogens, other intestinal microbes and antimicrobial resistance will be investigated
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2010
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 13, 2010
CompletedFirst Posted
Study publicly available on registry
January 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedMay 26, 2021
August 1, 2015
2.5 years
November 13, 2010
May 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Type of pathogens in stool samples in percentage of included patients
The percentage of included patients with different pathogens will be described.
2 years
Secondary Outcomes (2)
Type of microbes other than than pathogens in stool samples in percentage of included patients
2 years
The patern of resistance to antimicrobials in isolated pathogens
2 years
Study Arms (8)
Children with diarrhea in Bissau
Children without diarrhea in Bissau
Children without diarrhea in Finland
Children with diarrhea in Finland
Adults without diarrhea in Finland
Adults with diarrhea in Finland
Adults without diarrhea in Bissau
Adults with diarrhea in Bissau
Eligibility Criteria
1. children and adults with diarrhea reporting to Bandim Health Centre 2. age and sex mached children and adults without diarrhea from Bandim 3. children and adults with a recent travel history and suffering from diarrhea reporting to Postitalo Travel Clinic 4. children and adults without diarrhea and no recent travel history reporting to Postitalo Travel Clinic
You may qualify if:
- Accepting to participate and willing to deliver 2 stool samples.
- With diarrhea: the first 10 children and 10 adults presenting each month at the health facility Without diarrhea: In Bissau matched controls drawn from the registration system at Bandim Health Project. In Finland controls selected at the health facilities participating.
You may not qualify if:
- Not willing or able to deliver the stool samples
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bandim Health Projectlead
- University of Helsinkicollaborator
- Stockholm Universitycollaborator
Study Sites (3)
Postitalo Travel Clinic
Helsinki, 3448, Finland
University of Helsinki
Helsinki, 3448, Finland
Bandim Health Centre
Bissau, 1004 Bissau Codex, Guinea-Bissau
Biospecimen
Faecea samples are collected for analysis of patogens
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anu Kantele, Ph.d
Helsinki University Central Hospital,Dept of Medicine, Division of Infectious Diseases, Aurora Hospital, Building 5, Floor 3, POB 3448, FIN-00029 HUS
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2010
First Posted
January 4, 2011
Study Start
November 1, 2010
Primary Completion
May 1, 2013
Study Completion
July 1, 2015
Last Updated
May 26, 2021
Record last verified: 2015-08